Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes-Reference-Cited by-同舟云学术

Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes

Published:2017-09-28 Issue: Volume:23 Page:4657-4664
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Wang Junbin¹,Zheng Rongsheng¹,Wang Zishu¹,Yang Yan¹,Wang Mingxi¹,Zou Weiyan²

Affiliation:

1. Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China (mainland)

2. Department of Histology and Embryology, Bengbu Medical College, Bengbu, Anhui, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular characterization of the vinorelbine-platinum chemotherapeutic regimen in HER2(-) metastatic breast cancer;2024-06-20

2. Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study;Surgery Open Science;2023-12

3. Vinorelbine plus platinum compared to vinorelbine plus capecitabine in treatment of patients with metastatic triple negative breast cancer previously treated with anthracycline and taxane: a prospective randomized study;Oncology in Clinical Practice;2023-09-18

4. FTO‐mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR‐1343‐3p;The Kaohsiung Journal of Medical Sciences;2023-08-16

5. Vaginal metastasis from breast cancer: A case report;Open Life Sciences;2023-01-01